USPTO serial 87470542
MTF BIOLOGICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 15, 2019
- Examiner
- DINALLO, KEVIN M
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with MTF BIOLOGICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Musculoskeletal Transplant Foundation
Edison, NJ
Other trademarks owned by Musculoskeletal Transplant Foundation
Musculoskeletal Transplant Foundation
Edison, NJ
Other trademarks owned by Musculoskeletal Transplant Foundation
Musculoskeletal Transplant Foundation
Edison, NJ
Other trademarks owned by Musculoskeletal Transplant Foundation
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Allograft material, namely, processed human bone and tissue for use in surgical or medical procedures; Allograft material, namely, human bone and tissue processed into implants, scaffolds, powders, gels, pastes, putty, mats, films, strips, sheets, molded pieces, surgical patches, plugs, wound dressings, or wound coverings; Growth factors, namely, proteins for promoting tissue growth and repair, processed into surgical implants, scaffolds and plugs for the repair and replacement of human bone and tissue defects; Processed acellular human dermis and fascia tissue intended for subsequent implantation or for use in cosmetic surgery; Human allograft tissue derived from dermis; Human allograft tissue for topical use comprised of tissue from placental membranes; Human allograft tissue derived from placental tissue; Human allograft tissue derived from adipose matrix; Adipose cavity filler; Soft tissue implant for use in surgery; Bone void fillers consisting of biological materials; Bone void fillers consisting of natural materials; Cartilage implants derived from living tissue; Hydrated packaging containers specially designed for transporting and holding allograft implants made from living tissue and bone | ACTIVE | — |
| 010 | Allograft transplantation instruments, namely, forceps, lesion reamers, depth gauges, lesion gauges, surgical saws, namely, core saws, drivers, graft retrievers, dilators, tamps, guide bushings, guide pins, graft stations, alignment guides, mallets, wrenches, and chamfer tools; Allograft fixation devices, namely, pins; Autologous systems, namely, biological material transfer devices, namely, blood transfer devices for medical purposes having at least one cannula and kits comprised of a transfer device, container with a coagulation activator and a container with or without an anti-coagulant; Hydrated packaging containers specially designed for transporting and holding allograft implants made from synthetic materials; Surgical vise with moveable cutter clamp | ACTIVE | — |
| 040 | Human allograft tissue processing services, namely, preparing biological tissue for subsequent implantation in the human body | ACTIVE | — |
| 042 | Providing on-line non-downloadable computer software used to obtain organ and tissue procurement and to track organ and tissue donations and maintain a database of hospitals participating in organ and tissue donation programs, the foregoing software for use in the field of organ procurement and tissue banking; Providing temporary use of on-line non-downloadable computer software that functions as a screening database for organ and tissue donor referrals in the field of organ procurement and tissue banking, such software not used to monitor patient placement, turnover or procedure status | ACTIVE | — |
| 044 | Human allograft tissue bank donor services; Maintaining files and records concerning the donation of human tissue between and among the hospital, donor and recipient; Medical services in the field of human tissue, cells, bone and organ donations, namely, obtaining donor consent and human donor referrals, conducting donor screening surveys, collecting donor medical data, coordinating donor recoveries with outside entities, and providing statistical donor data to others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Musculoskeletal Transplant Foundation
- Other trademarks owned by Musculoskeletal Transplant Foundation
- Other trademarks owned by Musculoskeletal Transplant Foundation
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MTF BIOLOGICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 7, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Mar 7, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 5, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jan 15, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 15, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 12, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 11, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 10, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 10, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 28, 2018 | IUAF | USE AMENDMENT FILED | — |
| Nov 28, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 20, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 18, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 18, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 18, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 3, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 3, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 19, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 24, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 24, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 4, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 13, 2017 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Sep 12, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 12, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 1, 2017 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Sep 1, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 1, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 1, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 1, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 1, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 1, 2017 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 29, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2017 | NWAP | NEW APPLICATION ENTERED | — |